Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Australian Trial in Acute Hepatitis C (ATAHC)
NCT00192569Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Jul 2004
- Primary completion
- Jun 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa in hepatitis C virus infection, sponsored by The Kirby Institute. Started Jul 2004; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00192569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192569.